OpenAlex
PricingAboutJobs
Log inGet started
Work

A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection

HTML

Year: 2011
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdq714
Authors: R. Wong, D. Cunningham, Y. Barbachano, C. Saffery, J. Valle, T. Hickish, S. Mudan, G. Brown, A. Khan, A. Wotherspoon, A.S. Strimpakos, J. Thomas, S. Compton, Y.J. Chua, I. Chau
Institutions: Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, The Christie Hospital, The Christie NHS Foundation Trust, Royal Bournemouth Hospital, Poole Hospital
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: XELOX, capecitabine, oxaliplatin, bevacizumab, neoadjuvant chemotherapy, perioperative chemotherapy, unresectable liver metastases, conversion to resectability, hepatectomy, objective response rate, PET staging
SDG: Good health and well-being

Open Access status: bronze

Funders: Cancer Research UK, National Institute for Health and Care Research
Award: NIHR Senior Investigator Award
OpenAlex ID: W2142183513
FWCI: 12.81
Cites: 34
Cited by: 222
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security